Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 16/20 | 0.55 |
| ▸ | ALB | P02768 | 2/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6818554 | 0.90 | ALB (0.63) | FASNALB | |
| SCHEMBL7065738 | 0.80 | FASN (0.44) | FASN | |
| SCHEMBL6833057 | 0.79 | MEN1 (0.65) | ALBSERPINE1 | |
| SCHEMBL6830657 | 0.77 | ALB (0.59) | FASNALBSERPINE1 | |
| SCHEMBL6359401 | 0.77 | ALB (0.63) | ALBSERPINE1 | |
| SCHEMBL6834176 | 0.77 | ALB (0.61) | ALB | |
| SCHEMBL6352010 | 0.76 | ALB (0.81) | ALB | |
| SCHEMBL2278079 | 0.76 | HDAC2 (0.63) | — | |
| SCHEMBL6833717 | 0.76 | ALB (0.60) | FASNALBSERPINE1 | |
| Hydrochloric Acid SCHEMBL6834033 | 0.76 | ALB (0.65) | ALBSERPINE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | FASN 999/4885ALB 1417/4885MMP1 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.